(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 5.97% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Elanco Animal Health's revenue in 2026 is $4,715,000,000.On average, 17 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,531,082,680,007, with the lowest ELAN revenue forecast at $2,386,903,937,677, and the highest ELAN revenue forecast at $2,619,578,597,713. On average, 17 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,662,832,220,412, with the lowest ELAN revenue forecast at $2,481,365,872,307, and the highest ELAN revenue forecast at $2,780,661,054,661.
In 2028, ELAN is forecast to generate $2,788,118,575,816 in revenue, with the lowest revenue forecast at $2,608,640,900,019 and the highest revenue forecast at $2,946,715,192,379.